Literature DB >> 20406796

Auditing patient registration in the Swedish quality register for acute coronary syndrome.

Maria Rosvall1, Henrik Ohlsson, Ole Hansen, Basile Chaix, Juan Merlo.   

Abstract

AIMS: The present study aims to quantify non-participation in the RIKS-HIA register during 2005 and to compare acute myocardial infarction (AMI) patients registered and not registered in RIKS-HIA, in relation to sociodemographic factors, prevalent disease, and 7-day and 30-day survival.
METHODS: We linked information on sociodemographic characteristics, treatments, morbidity, and mortality from the LOMAS (Longitudinal Multilevel Analysis in Scania) database with the RIKS-HIA register. The study population consisted of individuals younger than 85 years living in Scania by 31 December 2004 who had one or more AMI during 2005 (n = 2968).
RESULTS: The 70% of the AMI patients included in the register were generally younger, more often men, generally more healthy, more often had AMI as the main diagnosis, and more often underwent revascularisation procedures than AMI patients not included. Among both men (OR(adjusted) = 0.19; 95% CI 0.14-0.27) and women (OR(adjusted) = 0.30; 95% CI 0.20-0.44), registered patients had a lower 30-day mortality than patients not registered in RIKS-HIA.
CONCLUSIONS: Even though RIKS-HIA conveys a clear quality improvement for the care of patients with acute coronary syndrome in Sweden, it is important to be aware that the register does not include the entire AMI population, but rather a selected and healthier population of AMI patients. This circumstance decreases the external validity of the information obtained from the RIKS-HIA register. Such an effect might be reduced over time and data from 2006 shows an inclusion rate of 76% among AMI patients aged less than 80 years.

Entities:  

Mesh:

Year:  2010        PMID: 20406796     DOI: 10.1177/1403494810365109

Source DB:  PubMed          Journal:  Scand J Public Health        ISSN: 1403-4948            Impact factor:   3.021


  4 in total

1.  Cost-effectiveness Analysis of Rivaroxaban in the Secondary Prevention of Acute Coronary Syndromes in Sweden.

Authors:  Najida Begum; Stephanie Stephens; Olaf Schoeman; Anina Fraschke; Bodo Kirsch; Jean-Baptiste Briere; Freek W A Verheugt; Ben A van Hout
Journal:  Cardiol Ther       Date:  2015-06-23

2.  Comparing routine administrative data with registry data for assessing quality of hospital care in patients with myocardial infarction using deterministic record linkage.

Authors:  Birga Maier; Katrin Wagner; Steffen Behrens; Leonhard Bruch; Reinhard Busse; Dagmar Schmidt; Helmut Schühlen; Roland Thieme; Heinz Theres
Journal:  BMC Health Serv Res       Date:  2016-10-21       Impact factor: 2.655

3.  Cardiovascular diseases monitoring: lessons from population-based registries to address future opportunities and challenges in Europe.

Authors:  Luigi Palmieri; Giovanni Veronesi; Giovanni Corrao; Giuseppe Traversa; Marco M Ferrario; Giovanni Nicoletti; Anna Di Lonardo; Chiara Donfrancesco; Flavia Carle; Simona Giampaoli
Journal:  Arch Public Health       Date:  2018-06-28

4.  Likelihood of treatment in a coronary care unit for a first-time myocardial infarction in relation to sex, country of birth and socioeconomic position in Sweden.

Authors:  Dong Yang; Stefan James; Ulf de Faire; Lars Alfredsson; Tomas Jernberg; Tahereh Moradi
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.